Our end-to-end innovation ecosystem allows clients to architect intelligent and resilient solutions for future missions.
We're building value and opportunity by investing in cybersecurity, analytics, digital solutions, engineering and science, and consulting. Our culture of innovation empowers employees as creative thinkers, bringing unparalleled value for our clients and for any problem we try to tackle.
Empower People to Change the World®
Booz Allen Commercial delivers advanced cyber defenses to the Fortune 500 and Global 2000. We are technical practitioners and cyber-focused management consultants with unparalleled experience – we know how cyber attacks happen and how to defend against them.
Learn how we’re driving empowerment, innovation, and resilience to shape our vision for the future through a focus on environmental, social, and governance (ESG) practices that matter most.
Our 29,200 engineers, scientists, software developers, technologists, and consultants live to solve problems that matter. We’re proud of the diversity throughout our organization, from our most junior ranks to our board of directors and leadership team.
While the Federal Government is committed to executing a comprehensive COVID-19 vaccination campaign, the distribution of vaccines falls individually on state and local government support. In our blog series on the vaccine rollout, Booz Allen’s Chief Medical Officer Kevin Vigilante and our health experts examine best practices and lessons learned from across the health landscape, including potential strategies and approaches that could help state and local governments improve vaccination rollouts.
Local media coverage plays a valuable role in COVID-19 vaccine hesitancy—or confidence. During a time of national crisis, like the coronavirus pandemic, connecting constituents with trusted health information and clear messaging from sources such as local health officials can impact vaccine uptake.
Research has shown that the volume and frequency of media coverage influences public opinion. With a disproportionate number of articles emphasizing vaccine hesitancy, it could become a self-fulfilling prophecy. Negative vaccine media coverage may promote hesitancy, further complicating efforts by public health officials to achieve vaccine goals.
A quick scan of local media (i.e., newspapers, radio programs, and televisions shows) in five geographically dispersed states was conducted in February 2021. The states were strategically chosen based on having counties where the highest and lowest rates of vaccine uptake reflected a difference of at least 10%.
Results showed that most local COVID-19 vaccine media coverage was either neutral or positive. Thematically speaking, the coverage highlighted vaccine supply and logistical challenges, such as making appointments rather than hesitancy as the limiting factors.
However, now that vaccine supply has increased and some of the earlier logistical challenges have eased, the vaccine hesitancy debate in local headlines may shift to reflect safety concerns, such as the recent pause of the Johnson & Johnson vaccine. Local media coverage may also highlight vaccine resistance among certain sub-populations, such as minority communities or parents of youth who recently became eligible to receive the Pfizer vaccine.
Going forward, states and local health authorities should consider the following three strategies when crafting vaccine messaging to local populations:
Want to stay updated on the COVID-19 vaccine rollout? Check out our health innovation insights. And feel free to share this post with those you care about.